LIC decreases stake in Aurobindo Pharma
Life Insurance Corporation of India has decreased its shareholding in equity shares of Aurobindo Pharma Ltd. from 2,93,55,635 to 1,31,57,165 i.e., 5.01% to 2.265% of the paid-up capital of the said Company.
"There is a net decrease of 2.745 percent in holding during the period from 25.11.2021 to 12.09.2024,"LIC stated in a BSE filing.
Medical Dialogues team had earlier reported that the new injectable facility of Eugia Steriles Private Limited , a 100% subsidiary of Eugia Pharma Specialities Limited and a stepdown subsidiary of the Aurobindo Pharma, situated at Parawada Mandal, Anakapalli District, Andhra Pradesh, had received its first product approval from the US Food and Drug Administration (US FDA) for Lidocaine Hydrochloride Injection, USP, 1% (10 mg/mL) and 2% (20 mg/mL).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.